| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |